|
Feb 21
|
Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks
|
|
Feb 20
|
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
|
|
Feb 19
|
Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest
|
|
Nov 23
|
Amphastar initiated with an Equal Weight at Wells Fargo
|
|
Sep 19
|
Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns
|
|
Aug 28
|
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
|
|
Aug 9
|
Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 7
|
Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
|
|
Aug 7
|
Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates
|
|
Aug 7
|
Amphastar: Q2 Earnings Snapshot
|
|
Aug 7
|
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024
|
|
Jun 12
|
Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)
|
|
Jun 7
|
With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case
|
|
May 15
|
Implied Volatility Surging for Amphastar (AMPH) Stock Options
|
|
May 10
|
Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
|
|
May 10
|
Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
|
|
May 9
|
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
|
|
May 9
|
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
|
|
May 9
|
Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
|